Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis
About the study
This is a multi-center, open-label extension (OLE) study in patients with plaque psoriasis who have completed their participation in a previous plaque psoriasis study of ESK-001.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- Must have completed a prior ESK-001 study
- Men and Women must use highly effective methods of contraception for the entirety of the study
EXCLUSION CRITERIA
Exclusion Criteria:
- Pregnancy
- Received a prohibited concomitant medication
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Plaque Psoriasis
Age (in years)
18+
Phase
PHASE2
Participants needed
165
Est. Completion Date
Dec 30, 2026
Treatment type
INTERVENTIONAL
Sponsor
Alumis Inc
ClinicalTrials.gov identifier
NCT05739435
Study number
ESK-001-007
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?